Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 2 Thoracic 1

Conditions

Small Cell Lung Carcinoma 2 Carcinoma, Non-Small-Cell Lung 2 Melanoma 1 Lung Neoplasms 1

Interventions

pembrolizumab 92 Nivolumab 57 Cyclophosphamide 22 Ipilimumab 17 atezolizumab 15 Magnetic Resonance Spectroscopy 14 Specimen Handling 13 Radiosurgery 13 Paclitaxel 13 Interleukin-2 12 Docetaxel 12 fludarabine 11 Carboplatin 11 Pemetrexed 10 spartalizumab 9 Biopsy 9 durvalumab 8 Cisplatin 8 Radiotherapy 7 Immune Checkpoint Inhibitors 7 Blood Specimen Collection 7 cemiplimab 6 avelumab 6 aldesleukin 6 Taxes 6 Gemcitabine 6 Drug Therapy 6 Bevacizumab 6 trametinib 5 tislelizumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Melanoma × guadecitabine × Thoracic × Clear all

NCT04250246 2020-01-31

NIBIT-ML1

Italian Network for Tumor Biotherapy Foundation

Phase 2 Unknown

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡